USFDA conducted an inspection at Zydus Lifesciences Limited's manufacturing facility SEZ-1 at Pharmez, Ahmedabad from March 20 to March 24, 2023, the company announced through an exchange filing. The inspection was a pre-approval inspection (PAI) and a GMP Audit that concluded with three observations.
The company said that there were no data integrity related observations and the company is addressing these observations.
Zydus received final approval from USFDA for Lubiprostone Capsules, the company announced on March 24.
Zydus Lifesciences shares
Brazilian Model Larissa Reacts To Rahul Gandhi’s Claim Of Her Voting 22 Times In Haryana; Calls It 'Unbelievable'- Video
Kyunki Saas Bhi Kabhi Bahu Thi 2 Written Update, November 5: Mitali Gets Possessed, Attacks Angad
Bihar Assembly Elections 2025: Voting For First Phase Of NDA Vs Mahagathbandhan High-Stakes Battle To Begin Soon
'Rahul Gandhi Pagal Hai': Assam CM Himanta Biswa Sarma Demands Congress MP Be Officially Declared 'Mad' Over Indian Army Remark - VIDEO
The shares of Zydus Lifesciences on Friday closed at Rs 480.05, down by 0.47 per cent.
